In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma (HCC), the time to HCC recurrence and the effects of sustained viral eradication (SVR) by interferon (IFN)-based or IFN-free regimens on HCC recurrence remain unclear.
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon / Petta, S; Cabibbo, G; Barbara, M; Attardo, S; Bucci, L; Farinati, F; Giannini, E. G; Tovoli, F; Ciccarese, F; Rapaccini, G. L; Di Marco, M; Caturelli, E; Zoli, M; Borzio, F; Sacco, R; Virdone, R; Marra, F; Felder, M; Morisco, Filomena; Benvegnù, L; Gasbarrini, A; Svegliati Baroni, G; Foschi, F. G; Olivani, A; Masotto, A; Nardone, GERARDO ANTONIO PIO; Colecchia, A; Persico, M; Boccaccio, V; Craxì, A; Bruno, S; Trevisani, F; Cammà, C.. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - (2016). [10.1111/apt.13821]
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
MORISCO, FILOMENA;NARDONE, GERARDO ANTONIO PIO;
2016
Abstract
In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma (HCC), the time to HCC recurrence and the effects of sustained viral eradication (SVR) by interferon (IFN)-based or IFN-free regimens on HCC recurrence remain unclear.| File | Dimensione | Formato | |
|---|---|---|---|
|
APT 2016.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
248.91 kB
Formato
Adobe PDF
|
248.91 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
